Back to all studies
UnknownNCT06501339

Maintenance ECT for schizophrenia

This study has an unknown status. It is testing maintenance ECT for schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years

Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.

Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06501339. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

No specific site is confirmed in the available information. Check the official source for locations and remote participation.

In plain English

Key information made simple

What is this study testing?

This study is testing whether brain stimulation may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may take part in brain stimulation, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

Participation locations and format are not confirmed in the available information. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: August 10, 2024
Recruitment status
Unknown
Enrollment listed in the registry
40
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug, PROCEDURE
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Not clearly listed
Age range
From 18 Years to 60 Years
Official registry ID
NCT06501339
Official title
Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole on Psychopathology and Cerebral Perfusion in Clozapine-resistant Schizophrenia: a Randomized, Double-blind Controlled Trial
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06501339. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Confirm the location and whether remote participation is possible with the research team.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring brain stimulation for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving maintenance ECT, Aripiprazole tablet. Phase 4 studies usually happen after treatment approval, to monitor real-world use.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 60 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by All India Institute of Medical Sciences, Bhubaneswar, which appears to be a research institute. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me